Evidence map›Paper›PMID 26764335›Full record

ReviewThe Journal of nutrition2016

Garlic-Derived Organic Polysulfides and Myocardial Protection.

Jessica M Bradley, Chelsea L Organ, David J Lefer

2 registry-linked trialsOpen access · bronzeAbstract readReview
In one paragraph

Review in The Journal of nutrition, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
27.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05803759 phase4unknown statusnot on this mapstarted 2023, after this paper: background citation

The Effects of Dietary Supplementation Allicor on the Effectiveness of Treatment of Patients After Coronary Arteria Revascularization

TypeinterventionalSponsorInstitute for Atherosclerosis Research, RussiaRan2023 to 2025Enrolled200ConditionsMyocardial Ischemia, Coronary Artery Bypass Grafting, Coronary Arteriosclerosis, Percutaneous Coronary RevascularizationArmsAllicor, Placebo
NCT05813171 phase4unknown statusnot on this mapstarted 2023, after this paper: background citation

The Effects of Dietary Supplementation Allicor on Patients With Multifocal Atherosclerosis After Peripheral Artery Revascularization Treatment During a Year

TypeinterventionalSponsorInstitute for Atherosclerosis Research, RussiaRan2023 to 2024Enrolled300ConditionsAtherosclerosis, Peripheral Arterial DiseaseArmsAllicor, Placebo
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 117 citations in OpenAlex.

  1. Review
  2. Larvicidal Activity of Solvent Extracts of Combined Garlic (Parasite epidemiology and control · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Protective Role of HDiabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. The interplay of hydrogen sulfide and microRNAs in cardiovascular diseases: insights and future perspectives.Mammalian genome : official journal of the International Mammalian Genome Society · 2024
    Review
  11. Review
  12. Review
  13. Using mechanism-based combinations of HNaunyn-Schmiedeberg's archives of pharmacology · 2024
    Article
  14. Article
  15. Review
  16. Review
  17. Diabetic Nephropathy and Gaseous Modulators.Antioxidants (Basel, Switzerland) · 2023
    Review
  18. Article
  19. Larvicidal Activities ofBioMed research international · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jessica M BradleyDepartment of Pharmacology and Experimental Therapeutics and Cardiovascular Center of Excellence, LSU Health Sciences Center, New Orleans, LA.
Chelsea L OrganDepartment of Pharmacology and Experimental Therapeutics and Cardiovascular Center of Excellence, LSU Health Sciences Center, New Orleans, LA.
David J LeferDepartment of Pharmacology and Experimental Therapeutics and Cardiovascular Center of Excellence, LSU Health Sciences Center, New Orleans, LA dlefe1@lsuhsc.edu.
Louisiana State University Health Sciences Center New Orleans · US

Funding

Preclinical Consortium to Facilitate Translation of Cardioprotective TherapiesU24HL094373 · NHLBI · UNIVERSITY OF LOUISVILLE · PI BOLLI, ROBERTO · 2010 to 2014
$9.6M
Functional Cardio-MetabolomicsP20HL113452 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI HAZEN, STANLEY L, TANG, WAI HONG WILSON · 2012 to 2016
$4.8M
Cardioprotective Actions of Hydrogen SulfideR01HL092141 · NHLBI · LSU HEALTH SCIENCES CENTER · PI LEFER, DAVID JOSEPH · 2009 to 2013
$1.9M
Nitrite Mediated CardioprotectionR01HL093579 · NHLBI · LSU HEALTH SCIENCES CENTER · PI LEFER, DAVID JOSEPH · 2009 to 2012
$1.5M
NHLBI NIH HHS 1P20 HL113452NHLBI NIH HHS 1R01 HL092141NHLBI NIH HHS 1R01 HL093579NHLBI NIH HHS 1U24 HL 094373
6 · The paper itself

Abstract

For centuries, garlic has been shown to exert substantial medicinal effects and is considered to be one of the best disease-preventative foods. Diet is important in the maintenance of health and prevention of many diseases including cardiovascular disease (CVD). Preclinical and clinical evidence has shown that garlic reduces risks associated with CVD by lowering cholesterol, inhibiting platelet aggregation, and lowering blood pressure. In recent years, emerging evidence has shown that hydrogen sulfide (H2S) has cardioprotective and cytoprotective properties. The active metabolite in garlic, allicin, is readily degraded into organic diallyl polysulfides that are potent H2S donors in the presence of thiols. Preclinical studies have shown that enhancement of endogenous H2S has an impact on vascular reactivity. In CVD models, the administration of H2S prevents myocardial injury and dysfunction. It is hypothesized that these beneficial effects of garlic may be mediated by H2S-dependent mechanisms. This review evaluates the current knowledge concerning the cardioprotective effects of garlic-derived diallyl polysulfides.

Indexed as

MyocardiumPhytotherapyCardiovascular AgentsDisulfidesGarlicHeartHumansHydrogen SulfidePlant ExtractsSulfidesSulfinic AcidsallicinCardiovascular AgentsDisulfidesHydrogen SulfidePlant ExtractspolysulfideSulfidesSulfinic Acidsacute myocardial infarctioncardioprotectionheart failurehydrogen sulfidenitric oxide

Identifiers

PMID26764335
PMCPMC4725427
OpenAlexW2234762254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.